Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001434265-25-000092
Filing Date
2025-11-06
Accepted
2025-11-06 11:11:39
Documents
14
Period of Report
2025-11-06

Document Format Files

Seq Description Document Type Size
1 6-K gmab_20251106x6k.htm 6-K 13023
2 EX-99.1 genmabinterimreportq32025.htm EX-99.1 1027296
3 GRAPHIC gmab_20250508xex99d1002.jpg GRAPHIC 4880
4 GRAPHIC gmab_20250508xex99d1004a.jpg GRAPHIC 23066
5 GRAPHIC gmab_20250508xex99d1005a.jpg GRAPHIC 36665
6 GRAPHIC gmab_20250508xex99d1006a.jpg GRAPHIC 1611
7 GRAPHIC gmab_20250508xex99d1007a.jpg GRAPHIC 2062
8 GRAPHIC gmab_20250508xex99d1008a.jpg GRAPHIC 2922
9 GRAPHIC gmab_20250508xex99d1009a.jpg GRAPHIC 2301
10 GRAPHIC gmab_20250508xex99d1010a.jpg GRAPHIC 2771
11 GRAPHIC gmab_20250508xex99d1011a.jpg GRAPHIC 33325
12 GRAPHIC gmab_20250508xex99d1012a.jpg GRAPHIC 19238
13 GRAPHIC gmab_20250508xex99d1013a.jpg GRAPHIC 322406
14 gmab_20250508xex99d1014a.jpg GRAPHIC 9625
  Complete submission text file 0001434265-25-000092.txt   1629220
Mailing Address TOLDBODGADE 33 1253 COPENHAGEN K G7 00000
Business Address TOLDBODGADE 33 1253 COPENHAGEN K G7 00000
GENMAB A/S (Filer) CIK: 0001434265 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38976 | Film No.: 251456830
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)